Cargando…

Donor‐transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation

Detalles Bibliográficos
Autores principales:	Ghandili, Susanne, Kluger, Malte A., Leitner, Theo, Grahammer, Florian, Kirchner, Lennart, Modemann, Franziska, Achilles, Eike‐Gert, Kreipe, Hans H., Klein, Janin, Steinemann, Doris, Wolschke, Christine, Fischer, Lutz, Bokemeyer, Carsten, Fiedler, Walter, Huber, Tobias B., Alsdorf, Winfried H., Mahmud, Maida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321064/ https://www.ncbi.nlm.nih.gov/pubmed/35428972 http://dx.doi.org/10.1111/bjh.18194

Ejemplares similares

Ravulizumab in Preemptive Living Donor Kidney Transplantation in Hereditary Atypical Hemolytic Uremic Syndrome
por: Schmidt, Tilman, et al.
Publicado: (2022)

A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies
por: Ghandili, Susanne, et al.
Publicado: (2021)

COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress
por: Modemann, Franziska, et al.
Publicado: (2022)

Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis
por: Modemann, Franziska, et al.
Publicado: (2022)

Imaging findings in recurrent extramedullary leukaemias
por: Arrigan, M., et al.
Publicado: (2013)

Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment
por: Ghandili, Susanne, et al.
Publicado: (2022)

Standardized Supportive Care Documentation Improves Safety of High‐Dose Methotrexate Treatment
por: Alsdorf, Winfried H., et al.
Publicado: (2020)

Extramedullary disease in acute promyelocytic leukaemia: A rare presentation
por: Kasinathan, Ganesh, et al.
Publicado: (2020)

Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
por: Karagiannis, Panagiotis, et al.
Publicado: (2020)

Clinical features of hepatitis E infections in patients with hematologic disorders
por: Ghandili, Susanne, et al.
Publicado: (2022)

HLA-Haploidentical Family Donors: The New Promise for Childhood Acute Lymphoblastic Leukaemia?
por: Ab Rahman, Syaza, et al.
Publicado: (2022)

Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysis
por: von Kroge, Philipp H., et al.
Publicado: (2023)

Long‐term remission of extramedullary cutaneous relapse of acute myeloid leukaemia (leukaemia cutis) treated with decitabine‐venetoclax
por: Maravalle, Denise, et al.
Publicado: (2022)

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation
por: Gagelmann, Nico, et al.
Publicado: (2023)

Acute Myeloid Leukaemia of Donor Cell Origin Developing 17 Years after Allogenic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukaemia
por: Jiménez, Pilar, et al.
Publicado: (2012)

Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
por: Ghandili, Susanne, et al.
Publicado: (2020)

Acceptance of Donor Eggs, Donor Sperms, or Donor Embryos in Indian Infertile Couples
por: Banerjee, Kaberi, et al.
Publicado: (2018)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
por: Dai, Hanren, et al.
Publicado: (2015)

Donor heart selection: the outcome of "unacceptable" donors
por: Khasati, Noman H, et al.
Publicado: (2007)

Family/friend donors are not true voluntary donors
por: Jain, Rohit, et al.
Publicado: (2012)

Donor Infection: An Opinion on Lung Donor Utilization
por: Garrity, Edward R., et al.
Publicado: (2005)

Consensus conference on unrelated donor BMT: Its use in leukaemias and allied disorders 29-30 October 1996
Publicado: (1997)

Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients
por: Madanchi, Ramin, et al.
Publicado: (2022)

Donor Smoking Negatively Affects Donor and Recipient Renal Function following Living Donor Nephrectomy
por: Heldt, Jonathan, et al.
Publicado: (2011)

Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022)

Investigating the Effects of Donors and Alkyne Spacer on the Properties of Donor-Acceptor-Donor Xanthene-Based Dyes
por: Rajapaksha, Ishanka N., et al.
Publicado: (2023)

Recruiting unrelated donors for the National Marrow Donor Program.
por: Yanke, D. R.
Publicado: (1990)

Gamete donors' expectations and experiences of contact with their donor offspring
por: Kirkman, Maggie, et al.
Publicado: (2014)

Analysis of Donor Motivations in Living Donor Liver Transplantation
por: Abdeldayem, Hesham, et al.
Publicado: (2014)

(Non‐)donor demographics, donation willingness, and the donor career
por: Piersma, Tjeerd W., et al.
Publicado: (2019)

Orchialgia After Living Donor Nephrectomy: An Underreported Entity
por: Schoephoerster, Jamee, et al.
Publicado: (2022)

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia
por: Foley, Bree, et al.
Publicado: (2020)

Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet
por: Nakamura, Hitomi, et al.
Publicado: (2021)

EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma
por: Akyüz, Nuray, et al.
Publicado: (2023)

Where Are the Donors?
Publicado: (1892)

Testing the Donor
por: Kitchen, Alan, et al.
Publicado: (2010)

Hybrids as NO Donors
por: Tsopka, Ioanna-Chrysoula, et al.
Publicado: (2021)

The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia
por: Wellbrock, Jasmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_onourr9rgdg859nmhhjqoo19b4